Clinical Trials Directory

Trials / Terminated

TerminatedNCT02027532

Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin

Prevention of Infection in Surgical Treatment of Closed Fractures: A Comparative Study of Cefazolin Versus Vancomycin

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
430 (actual)
Sponsor
University of Tennessee · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the incidence rate of infection in surgical patients with closed fractures treated prophylactically with Cefazolin versus Vancomycin in the peri-operative period. The hypothesis of this study is that patients undergoing surgical treatment for closed fractures who are treated prophylactically with Vancomycin will have a lower incidence rate of infection than patients who are treated prophylactically with Cefazolin.

Conditions

Interventions

TypeNameDescription
DRUGCefazolin
DRUGVancomycin

Timeline

Start date
2009-10-01
Primary completion
2015-06-01
Completion
2017-12-01
First posted
2014-01-06
Last updated
2018-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02027532. Inclusion in this directory is not an endorsement.